BxPC3 Pancreatic Cancer Cells Express a Truncated Smad4 Protein Upon PI3K and mTOR Inhibition

Oncology Letters - Greece
doi 10.3892/ol.2014.1833
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Inhibition of PI3K/mTOR Leads to Adaptive Resistance in Matrix-Attached Cancer Cells

Cancer Cell
Cancer ResearchOncologyCell Biology
2012English

Urolithin A, a Novel Natural Compound to Target PI3K/AKT/mTOR Pathway in Pancreatic Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Honokiol-Mediated Inhibition of PI3K/mTOR Pathway

Journal of immunotherapy (Hagerstown, Md. : 1997)
Cancer ResearchAllergyImmunologyPharmacology
2009English

Inhibition of STAT3Tyr705 Phosphorylation by Smad4 Suppresses Transforming Growth Factor -Mediated Invasion and Metastasis in Pancreatic Cancer Cells

Cancer Research
Cancer ResearchOncology
2008English

Macropinocytosis Renders a Subset of Pancreatic Tumor Cells Resistant to mTOR Inhibition

Cell Reports
BiochemistryGeneticsMolecular Biology
2020English

Dual PI3K/mTOR Inhibition in Colorectal Cancers withAPCandPIK3CAMutations

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2016English

Vertical Inhibition of the PI3K/Akt/mTOR Pathway Is Synergistic in Breast Cancer

Oncogenesis
Cancer ResearchMolecular Biology
2017English

Targeted Therapy for Advanced Prostate Cancer: Inhibition of the PI3K/Akt/mTOR Pathway

Current Cancer Drug Targets
Cancer ResearchDrug DiscoveryOncologyPharmacology
2009English

BEZ235 Impairs Gastric Cancer Growth by Inhibition of PI3K/mTOR in Vitro and in Vivo

BMC Pharmacology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy